The new company links and manages aspects of treatment delivery, facilitating access for patients to treatments by serving as a connector between manufacturers, patients, physicians, and payors.
PharmaCord, an independently owned healthcare services company located in Louisville, KY launched on Feb. 26, 2017. PharmaCord provides solutions that link reimbursement services, patient-centric pharmacy, care coordination, clinical services, and patient assistance programs through a technology-based platform. The company links and manages aspects of treatment delivery, facilitating access for patients to treatments by serving as a connector between manufacturers, patients, physicians, and payors.
“As an independently owned, fully funded company, we are developing the technology and tools to provide biopharmaceutical manufacturers with efficient solutions to address the barriers of access for specialty products treating chronic diseases,” said Nitin Sahney, the founder and CEO of PharmaCord, in a statement. “We are investing significantly into the development of our proprietary platform, Intersections. Starting with traditional hub services and consigned pharmacy, we layer on clinical and data analytics to create a powerful tool enabling us to operate efficiently, along with increasing the quality and accessibility of actionable data. Ultimately, branded and customized programs increase conversion to therapy and improve adherence through personalized targeted outreach.”
Source: PharmaCord
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.